Intensity Therapeutics, Common Stock Fundamentals
| INTS Stock | 2.23 0.02 0.90% |
Intensity Therapeutics, Common fundamentals help investors to digest information that contributes to Intensity Therapeutics,'s financial success or failures. It also enables traders to predict the movement of Intensity Stock. The fundamental analysis module provides a way to measure Intensity Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intensity Therapeutics, stock.
At this time, Intensity Therapeutics,'s Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 391.2 K in 2025, whereas Other Operating Expenses is likely to drop slightly above 7.9 M in 2025.
Intensity | Select Account or Indicator |
Intensity Therapeutics, Common Company Current Valuation Analysis
Intensity Therapeutics,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Intensity Therapeutics, Current Valuation | 30.74 M |
Most of Intensity Therapeutics,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intensity Therapeutics, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Intensity Current Valuation Historical Pattern
Today, most investors in Intensity Therapeutics, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Intensity Therapeutics,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Intensity Therapeutics, current valuation as a starting point in their analysis.
Intensity Therapeutics, Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Intensity Therapeutics, Common has a Current Valuation of 30.74 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is notably lower than that of the firm.
Intensity Therapeutics, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intensity Therapeutics,'s current stock value. Our valuation model uses many indicators to compare Intensity Therapeutics, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intensity Therapeutics, competition to find correlations between indicators driving Intensity Therapeutics,'s intrinsic value. More Info.Intensity Therapeutics, Common is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, Intensity Therapeutics,'s Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Intensity Therapeutics, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Intensity Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intensity Therapeutics,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Intensity Therapeutics, could also be used in its relative valuation, which is a method of valuing Intensity Therapeutics, by comparing valuation metrics of similar companies.Intensity Therapeutics, is currently under evaluation in current valuation category among its peers.
Intensity Therapeutics, Current Valuation Drivers
We derive many important indicators used in calculating different scores of Intensity Therapeutics, from analyzing Intensity Therapeutics,'s financial statements. These drivers represent accounts that assess Intensity Therapeutics,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Intensity Therapeutics,'s important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 69.3M | 75.9M | 81.3M | 65.4M | 75.3M | 80.6M |
Intensity Therapeutics, ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Intensity Therapeutics,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Intensity Therapeutics,'s managers, analysts, and investors.Environmental | Governance | Social |
Intensity Fundamentals
| Return On Equity | -1.74 | ||||
| Return On Asset | -0.95 | ||||
| Current Valuation | 30.74 M | ||||
| Shares Outstanding | 15.1 M | ||||
| Shares Owned By Insiders | 43.00 % | ||||
| Shares Owned By Institutions | 18.00 % | ||||
| Number Of Shares Shorted | 51.51 K | ||||
| Price To Book | 12.01 X | ||||
| EBITDA | (10.09 M) | ||||
| Net Income | (10.54 M) | ||||
| Total Debt | 158 K | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (7.21 M) | ||||
| Short Ratio | 1.44 X | ||||
| Earnings Per Share | (1.07) X | ||||
| Target Price | 10.0 | ||||
| Market Capitalization | 33.38 M | ||||
| Total Asset | 17.3 M | ||||
| Retained Earnings | (50.52 M) | ||||
| Working Capital | 11.51 M | ||||
| Net Asset | 17.3 M |
About Intensity Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Intensity Therapeutics, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intensity Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intensity Therapeutics, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 132.3 K | 130.4 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics,'s price analysis, check to measure Intensity Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics, is operating at the current time. Most of Intensity Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics,'s price. Additionally, you may evaluate how the addition of Intensity Therapeutics, to your portfolios can decrease your overall portfolio volatility.